D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 65 Citations 15,259 157 World Ranking 1381 National Ranking 704
Medicine D-index 73 Citations 17,850 218 World Ranking 13516 National Ranking 7049

Overview

What is he best known for?

The fields of study he is best known for:

  • Virus
  • Internal medicine
  • Gene

His scientific interests lie mostly in Immunology, Virology, Vaccination, Virus and Viral disease. In his study, Respiratory system is strongly linked to Respiratory disease, which falls under the umbrella field of Immunology. His biological study spans a wide range of topics, including Antibody, Immune system and Immunogenicity.

His Vaccination research is multidisciplinary, relying on both Orthomyxoviridae, Pediatrics and Nasal administration. In his research on the topic of Virus, Ribavirin and Pneumovirinae is strongly related with Human metapneumovirus. He works mostly in the field of Viral disease, limiting it down to topics relating to Incidence and, in certain cases, Epidemiology, Immunosuppression, Retrospective cohort study, Risk factor and Length of hospitalization, as a part of the same area of interest.

His most cited work include:

  • The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children (834 citations)
  • Impact of respiratory virus infections on persons with chronic underlying conditions. (480 citations)
  • Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. (386 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Immunology, Virology, Virus, Bronchiolitis and Pediatrics. His work in Immunology addresses subjects such as Respiratory disease, which are connected to disciplines such as Respiratory tract and Pneumonia. His research in Virology intersects with topics in Antibody, Immune system and Immunogenicity.

Pedro A. Piedra focuses mostly in the field of Virus, narrowing it down to matters related to Respiratory system and, in some cases, Disease and Viral load. The study incorporates disciplines such as Rhinovirus, Prospective cohort study, Severity of illness and Cohort study in addition to Bronchiolitis. His Vaccination study combines topics from a wide range of disciplines, such as Orthomyxoviridae and Nasal spray.

He most often published in these fields:

  • Immunology (39.92%)
  • Virology (39.51%)
  • Virus (36.63%)

What were the highlights of his more recent work (between 2017-2021)?

  • Bronchiolitis (28.81%)
  • Virus (36.63%)
  • Internal medicine (18.52%)

In recent papers he was focusing on the following fields of study:

His main research concerns Bronchiolitis, Virus, Internal medicine, Rhinovirus and Virology. He has included themes like Microbiome, Interquartile range, Metabolome, Prospective cohort study and Severity of illness in his Bronchiolitis study. The subject of his Virus research is within the realm of Immunology.

His Immunology study integrates concerns from other disciplines, such as Pregnancy, Disease and Gene expression profiling. His research in Rhinovirus intersects with topics in Respiratory tract infections, Asthma, Cohort study and Allergy. His Virology research includes elements of Adjuvant, Antibody, Whole genome sequencing and Primer.

Between 2017 and 2021, his most popular works were:

  • Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine. (265 citations)
  • NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge. (57 citations)
  • SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice (52 citations)

In his most recent research, the most cited papers focused on:

  • Virus
  • Internal medicine
  • Gene

His primary areas of study are Bronchiolitis, Rhinovirus, Internal medicine, Immunology and Virology. The various areas that Pedro A. Piedra examines in his Bronchiolitis study include Microbiome and Interquartile range. The Asthma and Cohort research he does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as Nasal Swab and Moraxella, therefore creating a link between diverse domains of science.

Particularly relevant to Virus is his body of work in Immunology. His work deals with themes such as Glycoprotein, Adjuvant and Antibody, Immunogenicity, which intersect with Virology. His Immunogenicity study incorporates themes from Tolerability, Immunization, Respiratory syncytial virus and Vaccination.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children

Robert B. Belshe;Paul M. Mendelman;John Treanor;James King.
The New England Journal of Medicine (1998)

1172 Citations

Impact of respiratory virus infections on persons with chronic underlying conditions.

W P Glezen;S B Greenberg;R L Atmar;P A Piedra.
JAMA (2000)

742 Citations

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

Robert B. Belshe;William C. Gruber;Paul M. Mendelman;Iksung Cho.
The Journal of Pediatrics (2000)

525 Citations

Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons

Núria Morral;Wanda O’Neal;Karen Rice;Michele Leland.
Proceedings of the National Academy of Sciences of the United States of America (1999)

482 Citations

Correlates of Immune Protection Induced by Live, Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine

Robert B. Belshe;William C. Gruber;Paul M. Mendelman;Harshvardhan B. Mehta.
The Journal of Infectious Diseases (2000)

457 Citations

Prospective Multicenter Study of Viral Etiology and Hospital Length of Stay in Children With Severe Bronchiolitis

Jonathan M. Mansbach;Pedro A. Piedra;Stephen J. Teach;Ashley F. Sullivan.
JAMA Pediatrics (2012)

383 Citations

Circulation Patterns of Group A and B Human Respiratory Syncytial Virus Genotypes in 5 Communities in North America

Teresa C. T. Peret;Caroline B. Hall;Gregory W. Hammond;Pedro A. Piedra.
The Journal of Infectious Diseases (2000)

373 Citations

Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children.

Pedro A. Piedra;Manjusha J. Gaglani;Claudia A. Kozinetz;Gayla Herschler.
Vaccine (2005)

342 Citations

Influenza virus infections in infants.

W. Glezen;Larry Taber;Arthur Frank;William Gruber.
Pediatric Infectious Disease Journal (1997)

329 Citations

Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates

Suzanne E. Ohmit;Mark G. Thompson;Joshua G. Petrie;Swathi N. Thaker.
Clinical Infectious Diseases (2014)

322 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Pedro A. Piedra

Janet A. Englund

Janet A. Englund

Seattle Children's Hospital

Publications: 89

Arnold S. Monto

Arnold S. Monto

University of Michigan–Ann Arbor

Publications: 75

Octavio Ramilo

Octavio Ramilo

The Ohio State University

Publications: 71

Asuncion Mejias

Asuncion Mejias

The Ohio State University

Publications: 69

Edward A. Belongia

Edward A. Belongia

Marshfield Clinic

Publications: 60

Richard K. Zimmerman

Richard K. Zimmerman

University of Pittsburgh

Publications: 55

Alicia M. Fry

Alicia M. Fry

Centers for Disease Control and Prevention

Publications: 52

Ann R. Falsey

Ann R. Falsey

Rochester Regional Health

Publications: 48

Kathleen M. Neuzil

Kathleen M. Neuzil

University of Maryland, Baltimore

Publications: 47

Robert B. Belshe

Robert B. Belshe

Saint Louis University

Publications: 46

Manjusha Gaglani

Manjusha Gaglani

Texas A&M University

Publications: 45

Carlos A. Camargo

Carlos A. Camargo

Harvard University

Publications: 44

Kanta Subbarao

Kanta Subbarao

University of Melbourne

Publications: 43

Edward E. Walsh

Edward E. Walsh

Rochester Regional Health

Publications: 42

Lisa A. Jackson

Lisa A. Jackson

Kaiser Permanente

Publications: 42

George Kemble

George Kemble

Sagimet Biosciences

Publications: 42

Something went wrong. Please try again later.